0001069530-21-000016.txt : 20210318
0001069530-21-000016.hdr.sgml : 20210318
20210318160633
ACCESSION NUMBER: 0001069530-21-000016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210317
FILED AS OF DATE: 20210318
DATE AS OF CHANGE: 20210318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FRIEDMANN NADAV
CENTRAL INDEX KEY: 0001245267
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29959
FILM NUMBER: 21754394
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASSAVA SCIENCES INC
CENTRAL INDEX KEY: 0001069530
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911911336
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7801 N CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 260
CITY: AUSTIN
STATE: TX
ZIP: 78731
BUSINESS PHONE: 512-501-2444
MAIL ADDRESS:
STREET 1: 7801 N CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 260
CITY: AUSTIN
STATE: TX
ZIP: 78731
FORMER COMPANY:
FORMER CONFORMED NAME: PAIN THERAPEUTICS INC
DATE OF NAME CHANGE: 20000309
4
1
certent-form4.xml
PRIMARY DOCUMENT
X0306
4
2021-03-17
0001069530
CASSAVA SCIENCES INC
SAVA
0001245267
FRIEDMANN NADAV
C/O CASSAVA SCIENCES, INC.
7801 N. CAPITAL OF TEXAS HWY.; SUITE 260
AUSTIN
TX
78731
1
1
0
0
Chief Medical Officer
Common Stock
2021-03-17
4
M
0
28015
53.55
A
92428
D
Common Stock
2021-03-17
4
F
0
23996
62.52
D
68429
D
Common Stock
53.55
2021-03-17
4
M
0
28015
53.55
D
2015-06-01
2021-06-01
Common Stock
28015
0
D
Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction.
/s/ Eric J. Schoen by Power of Attorney
2021-03-18